Free Trial
CVE:EMH

Emerald Health Therapeutics (EMH) Stock Price, News & Analysis

Emerald Health Therapeutics logo
C$0.26 -0.01 (-3.77%)
(As of 04/26/2021)

About Emerald Health Therapeutics Stock (CVE:EMH)

Key Stats

Today's Range
C$0.25
C$0.27
50-Day Range
C$0.26
C$0.26
52-Week Range
C$0.15
C$0.53
Volume
384,329 shs
Average Volume
644,760 shs
Market Capitalization
C$52.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Receive EMH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emerald Health Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

EMH Stock News Headlines

Emerald Princess
Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
University Hospitals Elyria Medical Center
Emerald Care Center Tulsa
See More Headlines

EMH Stock Analysis - Frequently Asked Questions

Emerald Health Therapeutics' stock was trading at C$0.26 at the beginning of the year. Since then, EMH stock has increased by 0.0% and is now trading at C$0.26.
View the best growth stocks for 2024 here
.

Shares of EMH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Emerald Health Therapeutics investors own include Aurora Cannabis (ACB), Alibaba Group (BABA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Trulieve Cannabis (TCNNF) and Canopy Growth (WEED).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
161
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$13.02 million
Cash Flow
C$0.33 per share
Book Value
C$0.40 per share

Miscellaneous

Free Float
N/A
Market Cap
C$52.28 million
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (CVE:EMH) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners